BOBO DONALD E JR 4

What Happened

• Donald E. Bobo Jr., CVP, Strategy & Corporate Development at Edwards Lifesciences (EW), exercised 11,340 stock options at $59.26 per share (cost $671,971) and then sold 11,340 shares in the open market at a weighted average price of $85.93 per share (gross proceeds $974,430) on March 2, 2026. The net difference between the sale proceeds and exercise cost was about $302,459 (before taxes and fees).
• The filing also shows a derivative disposition of 11,340 shares at $0.00, which is reported as part of the exercise/settlement activity on the same date.

Key Details

• Transaction date: March 2, 2026.
• Exercise: 11,340 shares at $59.26 each — total $671,971.
• Sale: 11,340 shares at weighted avg $85.93 — total $974,430; sale executed in multiple trades at $85.665–$86.380 (weighted avg reported).
• Footnote: Transactions were made under a Rule 10b5‑1 trading plan adopted February 27, 2025.
• Shares owned after the transaction: not specified in this Form 4 (filing notes it reflects only changes in beneficial ownership).
• Filing timeliness: reported same day (no late‑filing indication in the record).

Context

• This is effectively a cashless exercise (options exercised and the resulting shares sold the same day), a common way for insiders to realize value from equity awards. The presence of a 10b5‑1 plan means the trades were executed under a pre‑arranged program.